Study on Blood Pressure Variability and Frailty in the Older People

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age75+
SponsorIstituto Auxologico Italiano

About this trial

Observational prospective single-center, non-profit study. Primary objective of the study: To determine if the hypotensive phenotype, defined as one episode of daytime systolic blood pressure (SBP) \<90 mmHg (or two episodes of daytime SBP \<90 mmHg, if mean 24 h SBP is \<125 mmHg) detected at Ambulatory Blood Pressure Monitoring (ABPM) is associated with adverse events at follow up (death, hospitalization, falls, emergency room admission for uncontrolled hypertension, major cardiovascular events)

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 75 years

Diagnosis of hypertension according to the criteria of the European Society of Cardiology guidelines [Williams 2018]

Consent of the patient (or legal representative) to participate in the study

Disqualifiers

Refusal of the patient or his/her legal representative

Life expectancy of less than 6 months

Trial population

Elderly hypertensive patients who are enrolled at the Hypertension Centre of Istituto Auxologico italiano IRCCS

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Diagnostic tests and questionnaires

    Diagnostic test

    Assessment of office blood pressure, orthostatic hypotension, 24-hour ambulatory blood pressure, frailty

Treatment groups

220 Participants
are divided into 1 treatment group
Group A: Patients with hypertension, aged 75 years and older1 intervention

Trial outcomes

Primary outcomes

1

Incidence of adverse events

Adverse events at follow up (death, hospitalization, falls, emergency room admission for uncontrolled hypertension, major cardiovascular events)

Time frame
At 24 months of follow-up
2

Prevalence of hypotensive phenotype

Hypotensive phenotype, defined as one episode of daytime systolic blood pressure (SBP) \<90 mmHg (or two episodes of daytime SBP \<90 mmHg, if mean 24 h SBP is \<125 mmHg)

Time frame
At baseline

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.